TLX1/N fundamentals
TELIX PHARMACEUTIC financial statements, including revenue, expenses, profit, and loss
The total revenue of TLX1/N for the last semiannual is 4.45 B MXN, and it's 36.61% higher compared to the previous semiannual. The net income of H1 24 is 362.57 M MXN.
Q1 '24
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: MXN
Q1 '24
TTM